Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non‐insulin‐dependent Otsuka Long‐Evans Tokushima Fatty rats
Yoshihiro Kuno(Showa University), Tadao Akizawa(Showa University)
Cited by 72
Related Papers
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
|Kidney International|2016|474
Sleep quality predicts quality of life and mortality risk in haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
|Nephrology Dialysis Transplantation|2007|322
Japanese Society for Dialysis Therapy Clinical Guideline for “Hemodialysis Initiation for Maintenance Hemodialysis”
|Therapeutic Apheresis and Dialysis|2015|86
<scp>COVID</scp>‐19 of dialysis patients in Japan: Current status and guidance on preventive measures
|Therapeutic Apheresis and Dialysis|2020|68